28th Annual North American Cystic Fibrosis Conference

W24: NT: Innovative Approaches to CF Outcomes & Therapies

Oct 11, 2014 2:30pm ‐ Oct 11, 2014 4:15pm

Standard: $49.99


In this session the most recent data of clinical trials evaluating CFTR mutation-specific pharmacological therapeutics will be presented. Also, promising novel molecular therapies targeting CFTR mutations will be discussed.


You must be logged in and own this session in order to post comments.